Richard Altieri, Matthew McLaughlin, Elizabeth Keiley
Richard Altieri, chief financial officer for Oxford Immunotec, will retire on April 30, 2019. The company has appointed as his successor Matthew McLaughlin, currently CFO for GE Healthcare, US and Canada, a position he has held since December 2016. Prior to that he worked at GW Aviation, serving as CFO of Global Supply Chain from May 2014 to December 2016, CFO of GE Avionics from March 2012 to April 2014, and executive in financial planning and analysis from 2009 to February 2012.
Oxford Immunotec also disclosed in a filing with the US Securities and Exchange Commission that Elizabeth Keiley, senior vice president, general counsel, has resigned.